Fig. 12From: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MDObserved and predicted systemic exposure (AUC) following inhaled administration of SGRM using six different devices and formulations (12–18 healthy volunteers). The dashed line represents the identity line. Modified from (Olsson & Bäckman 2014)Back to article page